{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:00:50Z","timestamp":1762102850080,"version":"3.41.2"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Type 1 diabetes mellitus (T1DM) is a condition marked by elevated\nblood sugar levels and primarily recognized by the destruction of beta cells caused by an autoimmune\nattack, which is a significant characteristic of T1DM. Recent studies have demonstrated the\nregenerative potential of conditioned medium therapy. In light of this, the current research sought\nto assess the impact of Mesenchymal Stem Cell conditioned media (CM) and CM with resveratrol\n(CM+ Resveratrol) on the management of T1DM in Swiss albino mice. By leveraging and modifying\nexisting conditioned medium therapy, this study aims to evaluate its effectiveness in treating\nT1DM.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials &amp; Methods:<\/jats:title>\n<jats:p>Diabetes was induced in animals using the diabetes-inducing agent streptozotocin\n(STZ). The animals were then divided into five groups: Normal control, Disease Control,\nResveratrol, Condition Media, and CM + Resveratrol. Treatments were given to the animals accordingly.\nThe study period was 28 days. During this time, the animals were monitored for foodwater\nintake twice a week, blood glucose levels, and body weight. At the conclusion of the 28-day\nstudy period, biochemical estimations were performed for serum insulin levels, C-peptide levels,\nanti-inflammatory cytokines levels and pro-inflammatory cytokines levels. Additionally, histopathology\nof the pancreas was performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The test groups showed a significant decrease in blood glucose levels, an increase in Cpeptide\nlevels, and a decrease in pro-inflammatory cytokine levels compared to the disease group.\nHowever, no statistically significant change within groups was observed in terms of serum insulin\nand anti-inflammatory cytokine levels. The improvement in diabetic symptoms, such as polyphagia,\npolydipsia, and weight loss, was observed in the treatment group, along with pancreatic regeneration,\nwhich indicated improved insulin secretion.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In the current investigation, we concluded that CM and CM+ Resveratrol, as natural\nimmunomodulators, have the capacity to regenerate injured pancreatic beta cells and have antidiabetic\naction, together with immunomodulating impact. Nonetheless, future studies on this therapy\nappear to be promising.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115701638276524240305054259","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T07:02:57Z","timestamp":1710226977000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Mesenchymal Stem Cell-conditioned Media with Natural Immunomodulatory Agent Resveratrol on Type 1 Diabetes"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-7077","authenticated-orcid":true,"given":"Krushna","family":"Abhale","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veeranjaneyulu","family":"Addepalli","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Desai","sequence":"additional","affiliation":[{"name":"Clinical Research and Pharmacovigilance,\nSerum Institute of India Pvt. Ltd., Hadapsar, Pune"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash","family":"Sanap","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Laboratory, Dr. D. Y. Patil\nDental College and Hospital, Pimpri, Pune, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Bhonde","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Laboratory, Dr. D. Y. Patil\nDental College and Hospital, Pimpri, Pune, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00592-016-0847-z","volume":"53","author":"Pellegrini S.","year":"2016","unstructured":"Pellegrini S.; Cantarelli E.; Sordi V.; Nano R.; Piemonti L.; The state of the art of islet transplantation and cell therapy in type 1 diabetes. Acta Diabetol  2016,53(5),683-691","journal-title":"Acta Diabetol"},{"key":"ref=2","first-page":"139","volume":"17","author":"Wu H.","year":"2014","unstructured":"Wu H.; Mahato R.I.; Mesenchymal stem cell-based therapy for type 1 diabetes. Discov Med  2014,17(93),139-143","journal-title":"Discov Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2018.07.009","volume":"201","author":"Yi L.","year":"2018","unstructured":"Yi L.; Swensen A.C.; Qian W.J.; Serum biomarkers for diagnosis and prediction of type 1 diabetes. Transl Res  2018,201,13-25","journal-title":"Transl Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrendo.2016.30","volume":"12","author":"Op de Beeck A.","year":"2016","unstructured":"Op de Beeck A.; Eizirik D.L.; Viral infections in type 1 diabetes mellitus \u2014 why the \u03b2 cells? Nat Rev Endocrinol  2016,12(5),263-273","journal-title":"Nat Rev Endocrinol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","volume":"54","author":"Cnop M.","year":"2005","unstructured":"Cnop M.; Welsh N.; Jonas J.C.; J\u00f6rns A.; Lenzen S.; Eizirik D.L.; Mechanisms of pancreatic \u03b2-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes  2005,54(S2),S97-S107","journal-title":"Diabetes"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-9060-7_1","author":"Leung PS","year":"2010","unstructured":"Leung PS; Leung PS;  The Renin-Angiotensin System: Current Research Progress in The Pancreas  2010","journal-title":"The Renin-Angiotensin System: Current Research Progress in The Pancreas"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-90-481-3271-3_1","volume":"654","author":"In\u2019t Veld P","year":"2010","unstructured":"In\u2019t Veld P; Marichal M.; Microscopic anatomy of the human islet of Langerhans. Adv Exp Med Biol  2010,654,1-19","journal-title":"Adv Exp Med Biol"},{"key":"ref=8","first-page":"41","author":"Lew M","year":"2023","unstructured":"Lew M; Pang J.; Exocrine glands (Salivary Gland and Pancreas). Normal Cytology: An Illustrated, Practical Guide  2023,41-49","journal-title":"Normal Cytology: An Illustrated, Practical Guide"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/iub.1293","volume":"66","author":"Zhang J.","year":"2014","unstructured":"Zhang J.; Liu F.; Tissue-specific insulin signaling in the regulation of metabolism and aging. IUBMB Life  2014,66(7),485-495","journal-title":"IUBMB Life"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/bs.ircmb.2021.02.006","volume":"359","author":"Gil-Rivera M.","year":"2021","unstructured":"Gil-Rivera M.; Medina-Gali R.M.; Mart\u00ednez-Pinna J.; Soriano S.; Physiology of pancreatic \u03b2-cells: Ion channels and molecular mechanisms implicated in stimulus-secretion coupling. Int Rev Cell Mol Biol  2021,359,287-323","journal-title":"Int Rev Cell Mol Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.00008.2017","volume":"98","author":"Rorsman P.","year":"2018","unstructured":"Rorsman P.; Ashcroft F.M.; Pancreatic \u03b2-cell electrical activity and insulin secretion: Of mice and men. Physiol Rev  2018,98(1),117-214","journal-title":"Physiol Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/157339913804143225","volume":"9","author":"Fu Z.R.","year":"2013","unstructured":"Fu Z.R.; Gilbert E.; Liu D.; Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev  2013,9(1),25-53","journal-title":"Curr Diabetes Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"Atkinson M.A.","year":"2014","unstructured":"Atkinson M.A.; Eisenbarth G.S.; Michels A.W.; Type 1 diabetes. Lancet  2014,383(9911),69-82","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3389\/fphar.2018.01255","volume":"9","author":"Trung L.Q.","year":"2018","unstructured":"Trung L.Q.; An D.T.T.; Is resveratrol a cancer immunomodulatory molecule? Front Pharmacol  2018,9,1255","journal-title":"Front Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/nu13030728","volume":"13","author":"Shakoor H.","year":"2021","unstructured":"Shakoor H.; Feehan J.; Apostolopoulos V.; Platat C.; Al Dhaheri A.S.; Ali H.I.; Ismail L.C.; Bosevski M.; Stojanovska L.; Immunomodulatory effects of dietary polyphenols. Nutrients  2021,13(3),728","journal-title":"Nutrients"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/antiox9020091","volume":"9","author":"Gianchecchi E.","year":"2020","unstructured":"Gianchecchi E.; Fierabracci A.; Insights on the effects of resveratrol and some of its derivatives in cancer and autoimmunity: A molecule with a dual activity. Antioxidants  2020,9(2),91","journal-title":"Antioxidants"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"112164","DOI":"10.1016\/j.biopha.2021.112164","volume":"143","author":"Zhang L.X.","year":"2021","unstructured":"Zhang L.X.; Li C.X.; Kakar M.U.; Khan M.S.; Wu P.F.; Amir R.M.; Dai D.F.; Naveed M.; Li Q.Y.; Saeed M.; Shen J.Q.; Rajput S.A.; Li J-H.; Resveratrol (RV): A pharmacological review and call for further research. Biomed Pharmacother  2021,143,112164","journal-title":"Biomed Pharmacother"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/13813455.2021.1893338","volume":"129","author":"Hoca M.","year":"2021","unstructured":"Hoca M.; Becer E.; Vatansever H.S.; The role of resveratrol in diabetes and obesity associated with insulin resistance. Arch Physiol Biochem  2021,129(2),555-561","journal-title":"Arch Physiol Biochem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"118002","DOI":"10.1016\/j.lfs.2020.118002","volume":"256","author":"Maqsood M.","year":"2020","unstructured":"Maqsood M.; Kang M.; Wu X.; Chen J.; Teng L.; Qiu L.; Adult mesenchymal stem cells and their exosomes: Sources, characteristics, and application in regenerative medicine. Life Sci  2020,256,118002","journal-title":"Life Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s13287-020-02001-1","volume":"11","author":"Kangari P.","year":"2020","unstructured":"Kangari P.; Talaei-Khozani T.; Razeghian-Jahromi I.; Razmkhah M.; Mesenchymal stem cells: Amazing remedies for bone and cartilage defects. Stem Cell Res Ther  2020,11(1),492","journal-title":"Stem Cell Res Ther"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"Song N.","year":"2020","unstructured":"Song N.; Scholtemeijer M.; Shah K.; Mesenchymal stem cell immunomodulation: Mechanisms and therapeutic potential. Trends Pharmacol Sci  2020,41(9),653-664","journal-title":"Trends Pharmacol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"Galipeau J.","year":"2018","unstructured":"Galipeau J.; Sens\u00e9b\u00e9 L.; Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities. Cell Stem Cell  2018,22(6),824-833","journal-title":"Cell Stem Cell"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.stem.2021.09.006","volume":"28","author":"Krampera M.","year":"2021","unstructured":"Krampera M.; Le Blanc K.; Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy. Cell Stem Cell  2021,28(10),1708-1725","journal-title":"Cell Stem Cell"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","volume":"15","author":"Ilonen J.","year":"2019","unstructured":"Ilonen J.; Lempainen J.; Veijola R.; The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol  2019,15(11),635-650","journal-title":"Nat Rev Endocrinol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","volume":"31","author":"Warshauer J.T.","year":"2020","unstructured":"Warshauer J.T.; Bluestone J.A.; Anderson M.S.; New frontiers in the treatment of type 1 diabetes. Cell Metab  2020,31(1),46-61","journal-title":"Cell Metab"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1002\/cpz1.78","volume":"1","author":"Furman B.L.","year":"2021","unstructured":"Furman B.L.; Streptozotocin-induced diabetic models in mice and rats. Curr Protoc  2021,1(4),e78","journal-title":"Curr Protoc"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s00125-011-2064-1","volume":"54","author":"Lee S.M.","year":"2011","unstructured":"Lee S.M.; Yang H.; Tartar D.M.; Gao B.; Luo X.; Ye S.Q.; Zaghouani H.; Fang D.; Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia  2011,54(5),1136-1146","journal-title":"Diabetologia"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","volume":"17","author":"Roep B.O.","year":"2021","unstructured":"Roep B.O.; Thomaidou S.; van Tienhoven R.; Zaldumbide A.; Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?). Nat Rev Endocrinol  2021,17(3),150-161","journal-title":"Nat Rev Endocrinol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s002689900071","volume":"20","author":"Faist E.","year":"1996","unstructured":"Faist E.; Schinkel C.; Zimmer S.; Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg  1996,20(4),454-459","journal-title":"World J Surg"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.molmet.2017.06.019","volume":"6","author":"Chen C.","year":"2017","unstructured":"Chen C.; Cohrs C.M.; Stertmann J.; Bozsak R.; Speier S.; Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis. Mol Metab  2017,6(9),943-957","journal-title":"Mol Metab"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.addr.2017.07.006","volume":"114","author":"Chung L.","year":"2017","unstructured":"Chung L.; Maestas D.R.; Housseau F.; Elisseeff J.H.; Key players in the immune response to biomaterial scaffolds for regenerative medicine. Adv Drug Deliv Rev  2017,114,184-192","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.addr.2015.10.020","volume":"98","author":"Northrup L.","year":"2016","unstructured":"Northrup L.; Christopher M.A.; Sullivan B.P.; Berkland C.; Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity. Adv Drug Deliv Rev  2016,98,86-98","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cvsm.2010.01.004","volume":"40","author":"Thacker E.L.","year":"2010","unstructured":"Thacker E.L.; Immunomodulators, immunostimulants, and immunotherapies in small animal veterinary medicine. Vet Clin North Am Small Anim Pract  2010,40(3),473-483","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/nu9121306","volume":"9","author":"Oliveira A.L.","year":"2017","unstructured":"Oliveira A.L.; Monteiro V.V.; Navegantes-Lima K.C.; Reis J.F.; Gomes R.D.; Rodrigues D.V.; Gaspar S.L.; Monteiro M.C.; Natural immunomodulators role in autoimmune disease\u2014a mini-review. Nutrients  2017,9(12),1306","journal-title":"Nutrients"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"104754","DOI":"10.1016\/j.phrs.2020.104754","volume":"156","author":"Apaya M.K.","year":"2020","unstructured":"Apaya M.K.; Kuo T.F.; Yang M.T.; Yang G.; Hsiao C.L.; Chang S.B.; Lin Y.; Yang W.C.; Phytochemicals as modulators of \u03b2-cells and immunity for the therapy of type 1 diabetes: Recent discoveries in pharmacological mechanisms and clinical potential. Pharmacol Res  2020,156,104754","journal-title":"Pharmacol Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/ph15080912","volume":"15","author":"Sorrenti V.","year":"2022","unstructured":"Sorrenti V.; Benedetti F.; Buriani A.; Fortinguerra S.; Caudullo G.; Davinelli S.; Zella D.; Scapagnini G.; Immunomodulatory and antiaging mechanisms of resveratrol, rapamycin, and metformin: Focus on mTOR and AMPK signaling networks. Pharmaceuticals  2022,15(8),912","journal-title":"Pharmaceuticals"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1002\/ptr.7068","volume":"35","author":"Ali S.A.","year":"2021","unstructured":"Ali S.A.; Singh G.; Datusalia A.K.; Potential therapeutic applications of phytoconstituents as immunomodulators: Pre\u2010clinical and clinical evidences. Phytother Res  2021,35(7),3702-3731","journal-title":"Phytother Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3727\/215517913X666477","volume":"5","author":"Kasahara N.","year":"2013","unstructured":"Kasahara N.; Teratani T.; Doi J.; Iijima Y.; Maeda M.; Uemoto S.; Fujimoto Y.; Sata N.; Yasuda Y.; Kobayashi E.; Use of mesenchymal stem cell-conditioned medium to activate islets in preservation solution. Cell Med  2013,5(2-3),75-81","journal-title":"Cell Med"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27337","volume":"14","author":"Jayasinghe M.","year":"2022","unstructured":"Jayasinghe M.; Prathiraja O.; Perera P.B.; Jena R.; Silva M.S.; Weerawarna P.S.H.; Singhal M.; Kayani A.M.A.; Karnakoti S.; Jain S.; The role of mesenchymal stem cells in the treatment of type 1 diabetes. Cureus  2022,14(7)","journal-title":"Cureus"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/jdi.13045","volume":"10","author":"Makino E.","year":"2019","unstructured":"Makino E.; Nakamura N.; Miyabe M.; Ito M.; Kanada S.; Hata M.; Saiki T.; Sango K.; Kamiya H.; Nakamura J.; Miyazawa K.; Goto S.; Matsubara T.; Naruse K.; Conditioned media from dental pulp stem cells improved diabetic polyneuropathy through anti-inflammatory, neuroprotective and angiogenic actions: Cell-free regenerative medicine for diabetic polyneuropathy. J Diabetes Investig  2019,10(5),1199-1208","journal-title":"J Diabetes Investig"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1042\/CS20160235","volume":"130","author":"Yuan Y.","year":"2016","unstructured":"Yuan Y.; Shi M.; Li L.; Liu J.; Chen B.; Chen Y.; An X.; Liu S.; Luo R.; Long D.; Zhang W.; Newsholme P.; Cheng J.; Lu Y.; Mesenchymal stem cell-conditioned media ameliorate diabetic endothelial dysfunction by improving mitochondrial bioenergetics via the Sirt1\/AMPK\/PGC-1\u03b1 pathway. Clin Sci  2016,130(23),2181-2198","journal-title":"Clin Sci"},{"key":"ref=42","first-page":"47","volume":"7","author":"Sanap A.","year":"2021","unstructured":"Sanap A.; Bhonde R.; Joshi K.; Mesenchymal stem cell conditioned medium ameliorates diabetic serum-induced insulin resistance in 3T3-L1 cells. Chronic Dis Transl Med  2021,7(01),47-56","journal-title":"Chronic Dis Transl Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ijms24010095","volume":"24","author":"Moudgil K.D.","year":"2022","unstructured":"Moudgil K.D.; Venkatesha S.H.; The anti-inflammatory and immunomodulatory activities of natural products to control autoimmune inflammation. Int J Mol Sci  2022,24(1),95","journal-title":"Int J Mol Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.3390\/ijms24032360","volume":"24","author":"Shnayder N.A.","year":"2023","unstructured":"Shnayder N.A.; Ashhotov A.V.; Trefilova V.V.; Nurgaliev Z.A.; Novitsky M.A.; Vaiman E.E.; Petrova M.M.; Nasyrova R.F.; Cytokine imbalance as a biomarker of intervertebral disk degeneration. Int J Mol Sci  2023,24(3),2360","journal-title":"Int J Mol Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/jcb.25777","volume":"118","author":"Shree N.","year":"2017","unstructured":"Shree N.; Bhonde R.R.; Conditioned media from adipose tissue derived mesenchymal stem cells reverse insulin resistance in cellular models. J Cell Biochem  2017,118(8),2037-2043","journal-title":"J Cell Biochem"},{"key":"ref=46","author":"Masithoh DB","year":"2018","unstructured":"Masithoh DB; Fibrianto YH; Anggita M; Nugroho WS; Budipitojo T; PCS-11 mesenchymal stem cell-conditioned medium improve the recovery of pancreatic \u03b1 and \u03b2 cells in type 1 diabetes mellitus. Hemera Zoa  2018","journal-title":"Hemera Zoa"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701638276524240305054259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227818\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701638276524240305054259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T08:51:30Z","timestamp":1730278290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227818\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115701638276524240305054259","relation":{},"ISSN":["1570-1638"],"issn-type":[{"type":"print","value":"1570-1638"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e080324227818"}}